QA: Immucell CORP DE in us_medicinal_products/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000811641_2014_Immucell_CORP_DE.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000811641, Immucell CORP DE

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 635,619
2 remainder_Liabilities 929,226
3 AssetsCurrent 7,267,632
4 AssetsNoncurrent 13,636
5 PropertyPlantAndEquipmentNet 2,524,765
6 Goodwill 0
7 remainder_Assets 1,154,681
8 GeneralAndAdministrativeExpense 1,925,958
9 ResearchAndDevelopmentExpense 1,154,200
10 remainder_Expenses 2,809,623
11 remainder_Revenues 6,007,176
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Liabilities 1,564,845
1 Assets 10,960,714
2 Expenses 5,889,781
3 Revenues 6,007,176
4 StockholdersEquity 9,395,869
5 NetIncome 117,395
6 ComprehensiveNetIncome 117,395
7 BaseVar 12,211,258
8 EconomicCapitalRatiobeforeLimitedLiability 2.07
9 EconomicCapitalRatio 2.40

Edgar->Model Mapping

Feature Distribution

Change over Time